Beijing Airdoc Technology Past Earnings Performance
Past criteria checks 0/6
Beijing Airdoc Technology's earnings have been declining at an average annual rate of -24.2%, while the Healthcare Services industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 34.7% per year.
Key information
-24.2%
Earnings growth rate
1.3%
EPS growth rate
Healthcare Services Industry Growth | 22.3% |
Revenue growth rate | 34.7% |
Return on equity | -9.4% |
Net Margin | -65.0% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Investors Appear Satisfied With Beijing Airdoc Technology Co., Ltd.'s (HKG:2251) Prospects As Shares Rocket 33%
Apr 03Are Investors Undervaluing Beijing Airdoc Technology Co., Ltd. (HKG:2251) By 49%?
Mar 02We Think Beijing Airdoc Technology (HKG:2251) Can Afford To Drive Business Growth
Feb 02The Beijing Airdoc Technology Co., Ltd. (HKG:2251) Analysts Have Been Trimming Their Sales Forecasts
Sep 19Calculating The Intrinsic Value Of Beijing Airdoc Technology Co., Ltd. (HKG:2251)
Sep 01We're Not Very Worried About Beijing Airdoc Technology's (HKG:2251) Cash Burn Rate
Jun 09Revenue & Expenses BreakdownBeta
How Beijing Airdoc Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 204 | -133 | 209 | 112 |
30 Sep 23 | 181 | -125 | 197 | 112 |
30 Jun 23 | 159 | -117 | 184 | 113 |
31 Mar 23 | 136 | -149 | 182 | 119 |
31 Dec 22 | 114 | -180 | 180 | 126 |
30 Sep 22 | 108 | -192 | 181 | 118 |
30 Jun 22 | 103 | -205 | 181 | 110 |
31 Mar 22 | 109 | -174 | 166 | 87 |
31 Dec 21 | 115 | -143 | 150 | 64 |
30 Sep 21 | 103 | -102 | 113 | 57 |
30 Jun 21 | 91 | -62 | 76 | 49 |
31 Mar 21 | 69 | -56 | 60 | 46 |
31 Dec 20 | 48 | -50 | 44 | 42 |
31 Dec 19 | 30 | -47 | 29 | 40 |
Quality Earnings: 2251 is currently unprofitable.
Growing Profit Margin: 2251 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2251 is unprofitable, and losses have increased over the past 5 years at a rate of 24.2% per year.
Accelerating Growth: Unable to compare 2251's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2251 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.5%).
Return on Equity
High ROE: 2251 has a negative Return on Equity (-9.35%), as it is currently unprofitable.